Cancer Detection and Diagnosis Research in Missouri
Cancer Detection and Diagnosis Research (93.394) awarded $79.2 million to recipients in Missouri in 41 grants from fiscal 2021 to 2025, 2.9% of the program's national total. The Washington University received the most, $73.7 million.
- Awarded in Missouri$79.2 million
- Awards41
- Share of the program2.9%
- Rank among states9th of 45
- National total$2.7 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 17 | $11.0 million |
| FY 2022 | 23 | $16.1 million |
| FY 2023 | 30 | $19.9 million |
| FY 2024 | 29 | $16.2 million |
| FY 2025 | 22 | $16.0 million |
Recipients in Missouri
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| The Washington University | Colleges and universities | 37 | $73.7 million |
| Sarya LLC | Small businesses | 1 | $2.4 million |
| Cryocrate LLC | Small businesses | 1 | $1.8 million |
| Panome Bio Inc | Small businesses | 1 | $881,647 |
| University of Missouri System | Colleges and universities | 1 | $440,011 |
Open opportunities under this program
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
- Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)
- National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
- Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required)
- Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
- NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
See all 50 on the program page
Questions people ask
How much Cancer Detection and Diagnosis Research money goes to Missouri?
$79.2 million from fiscal 2021 to 2025, across 41 awards. Missouri ranks 9th of 45 states and territories for this program.
Who receives Cancer Detection and Diagnosis Research money in Missouri?
The largest recipient is The Washington University, with $73.7 million in 37 awards. Next are Sarya LLC and Cryocrate LLC.
Can organizations in Missouri apply now?
Yes, 50 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cancer Detection and Diagnosis Research in other states
Other large programs in Missouri
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- National School Lunch Program
- Children's Health Insurance Program
- Broadband Equity, Access, and Deployment Program
- Child Care and Development Block Grant
- Special Education Grants to States
- Title I Grants to Local Educational Agencies
- Temporary Assistance for Needy Families